BeiGene, Ltd. (BGNE) PT Raised to $295 at Morgan Stanley
Tweet
Share
E-mailGet Alerts BGNE Hot Sheet
Price: $184.71 --0%
Rating Summary:
17 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
17 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on BeiGene, Ltd. (NASDAQ: BGNE) to $295.00 (from $290.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Ascendis Pharma (ASND) PT Raised to $333 at Jefferies
- Adyen NV (ADYEN:NA) (ADYYF) PT Raised to EUR1,200 at Susquehanna
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
